Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00049561.xml
CC BY-NC-ND 4.0 · South Asian J Cancer 2014; 03(02): 147-148
DOI: 10.4103/2278-330X.130492
DOI: 10.4103/2278-330X.130492
Letters to Editor
Severe neurotoxicity due to Vinblastine in Hodgkin lymphoma
Publication History
Article published online:
31 December 2020
© 2014. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
-
1 Hausheer FH. Chemotherapy-Induced peripheral neuropathy. In: Perry MC, editor. The Chemotherapy Source Book. 4 th ed. Philadelphia: Lippincott Williams and Wilkins; 2008. p. 234-42.
-
2 Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F. Diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol 2006;33:15-49.
-
3 Eric KR. Antimicrotubule agents. In: Chabner BA, editor. Cancer Chemotherapy and Biotherapy: Principles and Practices. 4 th ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 241-2.
-
4 Eichenauer DA, Engert A, Dreyling M, ESMO Guidelines Working Group. Hodgkin′s lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncology 2011;22:vi55-8.
-
5 Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Bello CM, et al. National Comprehensive Cancer Network. Hodgkin lymphoma, version 2.2012.